Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Knowledge Production in Iranian Cardiovascular Research Centers: A Way to Reduce the Burden of Disease
Shahin Akhondzadeh Basti
Shahin Akhondzadeh Basti

Professor of Neuroscience

Department Psychiatry

School of Medicine

Roozbeh Hospital

Psychiatry and Psychology Research Center

Tehran University of Medical Sciences

All Documents
1. Comparing the Effect of Fluoxetine, Escitalopram, and Sertraline, on the Level of Bdnf and Depression in Preclinical and Clinical Studies: A Systematic Review, European Journal of Clinical Pharmacology (2024)
2. Efficacy and Safety of Celecoxib for Treatment of Mild to Moderate Postpartum Depression: A Randomized, Double-Blind, Placebo-Controlled Trial, Archives of Gynecology and Obstetrics (2024)
3. Emerging Drugs for the Treatment of Irritability Associated With Autism Spectrum Disorder, Expert Opinion on Emerging Drugs (2024)
4. Emerging Pharmacotherapy for the Treatment of Cannabis Use Disorder, Expert Opinion on Pharmacotherapy (2024)
5. Immunotherapy Perspectives for Pancreatic Ductal Adenocarcinoma (Pdac), Journal of Iranian Medical Council (2024)
6. Missile Attacks on Al-Ahli Hospital in Gaza and Silence of Reference International Authorities, Journal of Iranian Medical Council (2024)
7. Novel Osteoporosis Therapeutic Targets Derived From Medical Biotechnology, Avicenna Journal of Medical Biotechnology (2024)
8. The Association Between the Dietary Behavior, Diet Quality, and Lifestyle Scores With Anthropometric Indices and Happiness Levels Among University Students, BMC Nutrition (2024)
9. The Effects of Crocus Sativus (Saffron) on Adhd: A Systematic Review, Journal of Attention Disorders (2024)
10. The Role of Biotechnology in Latest Therapeutic Approaches for Diabetes Mellitus, Avicenna Journal of Medical Biotechnology (2024)
11. Celecoxib in Treatment of Postpartum Depression: A Case Report, Archives of Iranian Medicine (2023)
12. Cilostazol As Adjunctive Therapy in Treatment of Children With Autism Spectrum Disorders: A Double-Blind and Placebo-Controlled Randomized Trial, International Clinical Psychopharmacology (2023)
13. Classification of Suicidality by Training Supervised Machine Learning Models With Brain Mri Findings: A Systematic Review, Journal of Affective Disorders (2023)
14. Effect of Famotidine on Cognitive and Behavioral Dysfunctions Induced in Post-Covid-19 Infection: A Randomized, Double-Blind, and Placebo-Controlled Study, Journal of Psychosomatic Research (2023)
15. Effects of Antidepressant Medication on Brain-Derived Neurotrophic Factor Concentration and Neuroplasticity in Depression: A Review of Preclinical and Clinical Studies, Avicenna Journal of Medical Biotechnology (2023)
16. Efficacy and Safety of Adjunctive Therapy With Fingolimod in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Schizophrenia Research (2023)
17. Efficacy and Safety of Celecoxib Monotherapy for Treatment of Moderate Depressive Symptoms Following Covid-19 Infection: A Randomized, Double-Blind, Placebo-Controlled Trial, Journal of Psychosomatic Research (2023)
18. Efficacy and Tolerability of Lavandula Angustifolia in Treating Patients With the Diagnosis of Depression: A Systematic Review of Randomized Controlled Trials, Journal of Complementary and Integrative Medicine (2023)
19. Inflammation-Schizophrenia: A Bidirectional Causal Association Mediated by Cytokines, Avicenna Journal of Medical Biotechnology (2023)
20. Interdisciplinary Collaboration Between Bench and Bedside in the Covid-19 Pandemic, Avicenna Journal of Medical Biotechnology (2023)
21. Interdisciplinary Collaborations in the Pandemic Era Leading to Crisis Management and Medical Advances, Journal of Iranian Medical Council (2023)
22. L-Theanine Adjunct to Risperidone in the Treatment of Chronic Schizophrenia Inpatients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Psychopharmacology (2023)
23. L-Theanine Adjunct to Sertraline for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Journal of Affective Disorders (2023)
24. L-Theanine Combination Therapy With Fluvoxamine in Moderate-To-Severe Obsessive–Compulsive Disorder: A Placebo-Controlled, Double-Blind, Randomized Trial, Psychiatry and Clinical Neurosciences (2023)
25. Neuroimaging Correlates of Treatment Response to Transcranial Magnetic Stimulation in Bipolar Depression: A Systematic Review, Brain Sciences (2023)
26. Opium Tincture Versus Methadone for Opioid Agonist Treatment: A Randomized Controlled Trial, Addiction (2023)
27. Opium Tincture Versus Methadone for Opioid Agonist Treatment: A Randomized Controlled Trial, Addiction (2023)
28. Parkinson’S Disease: A Narrative Review on Potential Molecular Mechanisms of Sleep Disturbances, Rem Behavior Disorder, and Melatonin, Brain Sciences (2023)
29. Psychiatric Aspects of Chemical Warfare, Journal of Iranian Medical Council (2023)
30. Reboxetine Combination Therapy With Fluoxetine in Moderate to Severe Obsessive-Compulsive Disorder: A Placebo-Controlled, Double-Blind, Randomized Trial, Clinical Neuropharmacology (2023)
31. Response to [Palmitoylethanolamide: One Molecule, Different Formulations], Psychiatry and Clinical Neurosciences (2023)
32. Resting-State Functional Magnetic Resonance Imaging Alterations in Borderline Personality Disorder: A Systematic Review, Journal of Affective Disorders (2023)
33. The Anxiolytic Effects of Lavandula Angustifolia (Lavender): An Overview of Systematic Reviews, Journal of Herbal Medicine (2023)
34. The Clinician Scientist Training Program in Iran: Catalyzing Clinical Science Advancements, Avicenna Journal of Medical Biotechnology (2023)
35. Toward Personalized Psychiatry: Integrating Pharmacogenetics Into Psychiatry, Journal of Iranian Medical Council (2023)
36. What Is the Tolerance Limit of the Human Society in Face of the Killing of Innocent and Defenseless People of Gaza? Stop the Killing of Children and Infants in Gaza, Archives of Iranian Medicine (2023)
37. Adjuvant Palmitoylethanolamide Therapy With Risperidone Improves Negative Symptoms in Patients With Schizophrenia: A Randomized, Double-Blinded, Placebo-Controlled Trial, Psychiatry Research (2022)
38. Bidirectional Inflammation-Depression Associations and the Dynamic Intersection of Inflammation With Other Pathophysiological Correlates, Journal of Iranian Medical Council (2022)
39. Bioactive Components for Depression: Naringin, Caffeine, Probiotics, Saffron and Lavender May Exert Antidepressant Effects Through Inflammation Modulation, Journal of Iranian Medical Council (2022)
40. Cilostazol As an Adjunctive Treatment in Major Depressive Disorder: A Pilot Randomized, Double-Blind, and Placebo-Controlled Clinical Trial, Psychopharmacology (2022)
41. Clinician Guidelines for the Treatment of Psychiatric Disorders With Nutraceuticals and Phytoceuticals: The World Federation of Societies of Biological Psychiatry (Wfsbp) and Canadian Network for Mood and Anxiety Treatments (Canmat) Taskforce, World Journal of Biological Psychiatry (2022)
42. Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction Due to Attenuated Pathogenicity and Booster Vaccine Doses, Avicenna Journal of Medical Biotechnology (2022)
43. Corrigendum to “Possible Effects of Saffron (Crocus Sativus) in the Treatment of Erectile Dysfunction: A Randomized, Double-Blind, Placebo-Controlled Trial” [J. Herb. Med. 32 (2022) 100551](S2210803322000197)(10.1016/J.Hermed.2022.100551), Journal of Herbal Medicine (2022)
44. Crocus Sativus (Saffron) in the Treatment of Female Sexual Dysfunction: A Three-Center, Double-Blind, Randomized, and Placebo-Controlled Clinical Trial, Avicenna Journal of Phytomedicine (2022)
45. Efficacy and Safety of Palmitoylethanolamide As an Adjunctive Treatment for Acute Mania: A Randomized, Double-Blind, Placebo-Controlled Trial, Psychiatry and Clinical Neurosciences (2022)
46. Efficacy and Safety of Saffron As Adjunctive Therapy in Adults With Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Advances in Integrative Medicine (2022)
47. Efficacy of Spironolactone As an Adjunctive Therapy to Risperidone to Improve Symptoms of Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled, Clinical Trial, Iranian Journal of Psychiatry (2022)
48. Evidence for Anti-Inflammatory Effects of Adalimumab in Treatment of Patients With Major Depressive Disorder: A Pilot, Randomized, Controlled Trial, Clinical Neuropharmacology (2022)
49. Ketamine and Other Glutamate Receptor Modulating Agents for Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials, Iranian Journal of Psychiatry (2022)
50. Levetiracetam Adjunct to Quetiapine for the Acute Manic Phase of Bipolar Disorder: A Randomized, Double-Blind and Placebo-Controlled Clinical Trial of Efficacy, Safety and Tolerability, International Clinical Psychopharmacology (2022)
51. Melatonin Effects in Women With Comorbidities of Overweight, Depression, and Sleep Disturbance: A Randomized Placebo Controlled Clinical Trial, Sleep Medicine Research (2022)
52. Monkeypox Outbreaks in Non-Endemic Countries: What Do We Know and What Do We Need?, Avicenna Journal of Medical Biotechnology (2022)
53. Oxcarbazepine Versus Sodium Valproate in Treatment of Acute Mania: A Double-Blind Randomized Clinical Trial, International Clinical Psychopharmacology (2022)
54. Possible Effects of Saffron (Crocus Sativus) in the Treatment of Erectile Dysfunction: A Randomized, Double-Blind, Placebo-Controlled Trial, Journal of Herbal Medicine (2022)
55. Professor Moslem Bahadori (1927-2022), a Matchless Role Model in Modern Academic Medicine in Iran, Archives of Iranian medicine (2022)
56. Protection Against the Omicron and Subsequent Coronavirus Variants: Medical-Grade Masking, Third Dose Vaccination, Updating Vaccines, and Pursuing Universal Vaccine, Avicenna Journal of Medical Biotechnology (2022)
57. Risperidone Combination Therapy With Adalimumab for Treatment of Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, International Clinical Psychopharmacology (2022)
58. Substance of Choice, Impact of Heroin or Opium on Treatment Retention in a Multicentre Randomised Controlled Trial in Iran, Drug and Alcohol Review (2022)
59. The Inflammatory Mechanism in Depression and Some Possible Effective Agents, Journal of Iranian Medical Council (2022)
60. The Neuropsychotropic Effects of Crocus Sativus L. (Saffron): An Overview of Systematic Reviews and Meta-Analyses Investigating Its Clinical Efficacy in Psychiatric and Neurological Disorders, Avicenna Journal of Phytomedicine (2022)
61. Advances in Alternative and Integrative Medicine in the Treatment of Depression: A Review of the Evidence, Archives of Iranian Medicine (2021)
62. Atomoxetine As an Adjunct to Nonpharmacological Treatments for Preventing Vasovagal Attacks in Patients With Recurrent Vasovagal Syncope: A Pilot Randomized-Controlled Trial, IJC Heart and Vasculature (2021)
63. Effect of Sertraline on Depression Severity and Prolactin Levels in Women With Polycystic Ovary Syndrome: A Placebo-Controlled Randomized Trial, International Clinical Psychopharmacology (2021)
64. Efficacy and Safety of Pentoxifylline Combination Therapy in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, International Clinical Psychopharmacology (2021)
65. Efficacy and Safety of Sulforaphane for Treatment of Mild to Moderate Depression in Patients With History of Cardiac Interventions: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Psychiatry and Clinical Neurosciences (2021)
66. Efficacy and Safety of Tipepidine As Adjunctive Therapy in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Psychiatry and Clinical Neurosciences (2021)
67. Efficacy of Gemfibrozil As an Adjunct to Sertraline in Major Depressive Disorder, a Double-Blind, Randomized, and Placebo-Controlled Clinical Trial, Iranian Journal of Psychiatry (2021)
68. Evaluation and Research Ranking of Social Determinants of Health (Sdh) Research Centers in Iran: An Effective Step Towards Achieving Health Equity, Scientific Journal of Kurdistan University of Medical Sciences (2021)
69. Expectations of Health Researchers From Academic Social Network Sites: Qualitative Study, Journal of Medical Internet Research (2021)
70. Exposure to Cyberbullying, Cybervictimization, and Related Factors Among Junior High School Students, Iranian Journal of Psychiatry and Behavioral Sciences (2021)
71. Folinic Acid As Adjunctive Therapy in Treatment of Inappropriate Speech in Children With Autism: A Double-Blind and Placebo-Controlled Randomized Trial, Child Psychiatry and Human Development (2021)
72. How the Us Sanctions Are Affecting the Health Research System in Iran?, Archives of Iranian Medicine (2021)
73. Impact of Opioid Agonist Treatment on Mental Health in Patients With Opioid Use Disorder: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials, American Journal of Drug and Alcohol Abuse (2021)
74. Infectious Agents and Stroke: A Systematic Review, Basic and Clinical Neuroscience (2021)
75. Integrating Psychiatry and Medical Biotechnology As a Way to Achieve Scientific, Precision, and Personalized Psychiatry, Avicenna Journal of Medical Biotechnology (2021)
76. Investigating Gender Differences in Research Performance of Iranian Medical Faculty Members: A Scientometric Study, Tehran University Medical Journal (2021)
77. Medical Biotechnology in the Service of Coronavirus Vaccine Discovery and Production, Avicenna Journal of Medical Biotechnology (2021)
78. Medicinal Plants in the Treatment of Obsessive-Compulsive Disorder: A Review, Current Drug Discovery Technologies (2021)
79. Pentoxifylline for Treatment of Major Depression After Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: A Randomized, Double-Blind, Placebo-Controlled Trial, Journal of Psychosomatic Research (2021)
80. Prospects of Saffron and Its Derivatives in Alzheimer's Disease, Archives of Iranian Medicine (2021)
81. Psychotropic Effects of Saffron: A Brief Evidence-Based Overview of the Interaction Between a Persian Herb and Mental Health, Journal of Iranian Medical Council (2021)
82. Resveratrol Adjunct to Methylphenidate Improves Symptoms of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial, European Child and Adolescent Psychiatry (2021)
83. Significant Reduction in Hospitalization Due to Covid-19 As a Medium-Term Outcome Following Coronavirus Vaccination in Iran, Journal of Iranian Medical Council (2021)
84. The Effects of Opium Tincture and Methadone on the Cognitive Function of Patients With Opioid Use Disorder, Personality and Individual Differences (2021)
85. The Efficacy of Vitamin B6 As an Adjunctive Therapy to Lithium in Improving the Symptoms of Acute Mania in Patients With Bipolar Disorder, Type 1; a Double-Blind, Randomized, Placebo-Controlled, Clinical Trial, Brain and Behavior (2021)
86. The Interplay Between Gut Microbiota and Autism Spectrum Disorders: A Focus on Immunological Pathways, Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021)
87. The Necessity of Preserving the Research System in Emergency Eras, Archives of Iranian Medicine (2021)
88. The Requisiteness for Not Sacrificing Medical Biotechnology in the Coronavirus Era, Avicenna Journal of Medical Biotechnology (2021)
89. Vitamin E and Ginseng Combined Supplement for Treatment of Male Erectile Dysfunction: A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial, Advances in Integrative Medicine (2021)
90. 5-Hydroxytryptophan As Adjuvant Therapy in Treatment of Moderate to Severe Obsessive-Compulsive Disorder: A Double-Blind Randomized Trial With Placebo Control, International Clinical Psychopharmacology (2020)
91. A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder, Canadian Journal of Physiology and Pharmacology (2020)
92. A Placebo Controlled Randomized Clinical Trial of Crocus Sativus L. (Saffron) on Depression and Food Craving Among Overweight Women With Mild to Moderate Depression, Journal of Clinical Pharmacy and Therapeutics (2020)
93. A Tool to Reduce the Problems of Iranian Health Researchers, Iranian Journal of Public Health (2020)
94. Adding Extended-Release Methylphenidate to Psychological Intervention for Treatment of Methamphetamine Dependence: A Double-Blind Randomized Controlled Trial, Medical Journal of the Islamic Republic of Iran (2020)
95. Application of Saffron As a Neuroprotective Agent, Saffron: Science# Technology and Health (2020)
96. Basic Science and Clinical Studies on Non-Covid-19 Topics, of Coronavirus Victims, Avicenna Journal of Medical Biotechnology (2020)
97. Cinnamomum Tamala As an Adjuvant Therapy in the Treatment of Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial With Placebo Control, Advances in Integrative Medicine (2020)
98. Comparison of Vortioxetine and Sertraline for Treatment of Major Depressive Disorder in Elderly Patients: A Double-Blind Randomized Trial, Journal of Clinical Pharmacy and Therapeutics (2020)
99. Correction: A Comparative, Single-Blind, Randomized Study on Quetiapine and Aripiperazole Augmentation in Treatment of Selective Serotonin Reuptake Inhibitor Refractory Obsessive-Compulsive Disorder (Can. J. Physiol. Pharmacol., (2020) 98(4), (236-242), 10.1139/Cjpp-2019-0381), Canadian Journal of Physiology and Pharmacology (2020)
100. Development of Evaluation System for Iranian Health Research Networks: Challenges and Lessons Learned, Iranian Journal of Public Health (2020)
101. Does Pregnenolone Adjunct to Risperidone Ameliorate Irritable Behavior in Adolescents With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial?, Clinical Neuropharmacology (2020)
102. Effect of Covid-19 on Research: The Peer-Review Process and Ethical Issues Must Not Be Neglected, Journal of Iranian Medical Council (2020)
103. Efficacy and Safety of Sophora Alopecuroides Var. Alopecuroides Seed Extract for Opioid Detoxification: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial, Phytotherapy Research (2020)
104. Efficacy of Melatonin As an Adjunct in the Treatment of Acute Mania: A Double-Blind and Placebo-Controlled Trial, International Clinical Psychopharmacology (2020)
105. Evaluation of Drug and Alcohol Abuse in People Aged 15 Years and Older in Iran, Iranian Journal of Public Health (2020)
106. Is Transcranial Direct Current Stimulation an Effective Modality in Reducing Food Craving? a Systematic Review and Meta-Analysis, Nutritional Neuroscience (2020)
107. Knowledge Production in Iranian Cardiovascular Research Centers: A Way to Reduce the Burden of Disease, ARYA Atherosclerosis (2020)
108. Knowledge Production in Iranian Cardiovascular Research Centers: A Way to Reduce the Burden of Disease, ARYA Atherosclerosis (2020)
109. L-Carnosine Combination Therapy for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial, Journal of Affective Disorders (2020)
110. Lavender and Dodder Combined Herbal Syrup Versus Citalopram in Major Depressive Disorder With Anxious Distress: A Double-Blind Randomized Trial, Journal of Integrative Medicine (2020)
111. Lavender and Dodder Combined Herbal Syrup Versus Citalopram in Major Depressive Disorder With Anxious Distress: A Double-Blind Randomized Trial, Journal of Integrative Medicine (2020)
112. Prednisolone As Adjunctive Treatment to Risperidone in Children With Regressive Type of Autism Spectrum Disorder: A Randomized, Placebo-Controlled Trial, Clinical Neuropharmacology (2020)
113. Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial, International Journal of Neuropsychopharmacology (2020)
114. Resveratrol As Adjunctive Therapy in Treatment of Irritability in Children With Autism: A Double-Blind and Placebo-Controlled Randomized Trial, Journal of Clinical Pharmacy and Therapeutics (2020)
115. Sulforaphane As an Adjunctive Treatment for Irritability in Children With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Psychiatry and Clinical Neurosciences (2020)
116. The Equity in Access to Coronavirus Vaccination; an Ethical, Scientific and Economic Rationale, Journal of Iranian Medical Council (2020)
117. Vitamin E and Ginseng Supplementation to Enhance Female Sexual Function: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial, Women and Health (2020)
118. Vortioxetine As Adjunctive Therapy to Risperidone for Treatment of Patients With Chronic Schizophrenia: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial, Journal of Psychopharmacology (2020)
119. Vortioxetine Effects on Quality of Life of Irritable Bowel Syndrome Patients: A Randomized, Double-Blind, Placebo-Controlled Trial, Journal of Clinical Pharmacy and Therapeutics (2020)
120. Amantadine As Adjuvant Therapy in the Treatment of Moderate to Severe Obsessive–Compulsive Disorder: A Double-Blind Randomized Trial With Placebo Control, Psychiatry and Clinical Neurosciences (2019)
121. Baclofen As an Adjuvant Therapy for Autism: A Randomized, Double-Blind, Placebo-Controlled Trial, European Child and Adolescent Psychiatry (2019)
122. Bullying and Victimization Among Students Bears Relationship With Gender and Emotional and Behavioral Problems, Iranian Journal of Psychiatry (2019)
123. Comparing Opium Tincture and Methadone for Medication-Assisted Treatment of Patients With Opioid Use Disorder: Protocol for a Multicenter Parallel Group Noninferiority Double-Blind Randomized Controlled Trial, International Journal of Methods in Psychiatric Research (2019)
124. Comparing Opium Tincture and Methadone for Medication-Assisted Treatment of Patients With Opioid Use Disorder: Protocol for a Multicenter Parallel Group Noninferiority Double-Blind Randomized Controlled Trial, International Journal of Methods in Psychiatric Research (2019)
125. Crocus Sativus L. (Saffron) Versus Sertraline on Symptoms of Depression Among Older People With Major Depressive Disorders–A Double-Blind, Randomized Intervention Study, Psychiatry Research (2019)
126. Crocus Sativus L. (Saffron) Versus Sertraline on Symptoms of Depression Among Older People With Major Depressive Disorders–A Double-Blind, Randomized Intervention Study, Psychiatry Research (2019)
127. Crocus Sativus L. Versus Methylphenidate in Treatment of Children With Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study, Journal of Child and Adolescent Psychopharmacology (2019)
128. Depression and Inflammation: Is There Any Role for Biomarkers?, Avicenna Journal of Medical Biotechnology (2019)
129. Effect of Sweet Almond Syrup Versus Methylphenidate in Children With Adhd: A Randomized Triple-Blind Clinical Trial, Complementary Therapies in Clinical Practice (2019)
130. Efficacy and Safety of Tipepidine As Adjunctive Therapy in Children With Attention-Deficit/Hyperactivity Disorder: Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Psychiatry and Clinical Neurosciences (2019)
131. Fluvoxamine Combination Therapy With Tropisetron for Obsessive-Compulsive Disorder Patients: A Placebo-Controlled, Randomized Clinical Trial, Journal of Psychopharmacology (2019)
132. Herbal Medicine in the Treatment of Obsessive Compulsive Disorder: A Review, Journal of Medicinal Plants (2019)
133. Microbiome and Schizophrenia, Avicenna Journal of Medical Biotechnology (2019)
134. Microbiota and Autism Spectrum Disorder, Avicenna Journal of Medical Biotechnology (2019)
135. Monoclonal Antibody a Promising Treatment for Depression, Avicenna Journal of Medical Biotechnology (2019)
136. Possibility for Science Without Borders in the Trump Era, The Lancet (2019)
137. Riluzole for Treatment of Men With Methamphetamine Dependence: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Journal of Psychopharmacology (2019)
138. Risperidone Combination Therapy With Propentofylline for Treatment of Irritability in Autism Spectrum Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Clinical Neuropharmacology (2019)
139. Saffron: The Golden Spice With Therapeutic Properties on Digestive Diseases, Nutrients (2019)
140. The Characteristics, Reliability and Validity of the Persian Version of Simplified Nutritional Appetite Questionnaire (Snaq), Journal of Nutrition# Health and Aging (2019)
141. Therapeutic Effects of Saffron (Crocus Sativus) Versus Fluoxetine on Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial, Advances in Integrative Medicine (2019)
142. Acetaminophen As Adjuvant to Risperidone in Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Iranian Journal of Psychiatry (2018)
143. Attention-Deficit/Hyperactivity Disorder and Herbal Medicine: An Evidenced Based Approach, Journal of Medicinal Plants (2018)
144. Author's Reply to the Letter to the Editor by Fountoulakis, Pharmacopsychiatry (2018)
145. Citicoline (Cdp-Choline) Add-On Therapy to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial, Human Psychopharmacology (2018)
146. Does Oral Administration of Ketamine Accelerate Response to Treatment in Major Depressive Disorder? Results of a Double-Blind Controlled Trial, Journal of Affective Disorders (2018)
147. Effects of Saffron on Cognition, Anxiety, and Depression in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Double-Blind Placebo-Controlled Trial, Journal of Alternative and Complementary Medicine (2018)
148. Efficacy of Crocus Sativus (Saffron) in Treatment of Major Depressive Disorder Associated With Post-Menopausal Hot Flashes: A Double-Blind, Randomized, Placebo-Controlled Trial, Archives of Gynecology and Obstetrics (2018)
149. Fluoxetine for Multiple Sclerosis, Cochrane Database of Systematic Reviews (2018)
150. Herbal Medicine in the Treatment of Schizophrenia: A Review, Journal of Medicinal Plants (2018)
151. Infectious Agents and Different Course of Multiple Sclerosis: A Systematic Review, Acta Neurologica Belgica (2018)
152. Influence of Citicoline on Citalopram-Induced Antidepressant Activity in Depressive-Like Symptoms in Male Mice, Physiology and Behavior (2018)
153. L-Carnosine As Adjunctive Therapy in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Journal of Child and Adolescent Psychopharmacology (2018)
154. L-Carnosine As an Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial, Psychiatry Research (2018)
155. L-Carnosine As an Adjunctive Therapy to Risperidone in Children With Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial, Journal of Child and Adolescent Psychopharmacology (2018)
156. Monoclonal Antibody for Reducing Memory and Learning Problems in Schizophrenia, Avicenna Journal of Medical Biotechnology (2018)
157. Omega-3 Supplementation Effects on Body Weight and Depression Among Dieter Women With Co-Morbidity of Depression and Obesity Compared With the Placebo: A Randomized Clinical Trial, Clinical Nutrition ESPEN (2018)
158. Opioid Use Disorder Induces Oxidative Stress and Inflammation: The Attenuating Effect of Methadone Maintenance Treatment, Iranian Journal of Psychiatry (2018)
159. Palmitoylethanolamide As Adjunctive Therapy for Autism: Efficacy and Safety Results From a Randomized Controlled Trial, Journal of Psychiatric Research (2018)
160. Palmitoylethanolamide As Adjunctive Therapy in Major Depressive Disorder: A Double-Blind, Randomized and Placebo-Controlled Trial, Journal of Affective Disorders (2018)
161. Pexacerfont As a Crf1 Antagonist for the Treatment of Withdrawal Symptoms in Men With Heroin/Methamphetamine Dependence: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, International Clinical Psychopharmacology (2018)
162. Red Yeast Rice As an Adjunct to Sertraline for Treatment of Depression in Patients With Percutaneous Coronary Intervention: Placebo-Controlled Trial, Advances in Integrative Medicine (2018)
163. Setting Research Priorities to Achieve Long-Term Health Targets in Iran, Journal of Global Health (2018)
164. Setting Research Priorities to Achieve Long-Term Health Targets in Iran, Journal of Global Health (2018)
165. Simvastatin As an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Journal of Child and Adolescent Psychopharmacology (2018)
166. The Effect of Saffron (Crocus Sativus L.) Hydroalcoholic Extract on Metabolic Control in Type 2 Diabetes Mellitus: A Triple-Blinded Randomized Clinical Trial, Journal of Research in Medical Sciences (2018)
167. The Effects of Alcoholic Extract of Saffron (Crocus Satious L.) on Mild to Moderate Comorbid Depression-Anxiety, Sleep Quality, and Life Satisfaction in Type 2 Diabetes Mellitus: A Double-Blind, Randomized and Placebo-Controlled Clinical Trial, Complementary Therapies in Medicine (2018)
168. The Effects of Alcoholic Extract of Saffron (Crocus Satious L.) on Mild to Moderate Comorbid Depression-Anxiety, Sleep Quality, and Life Satisfaction in Type 2 Diabetes Mellitus: A Double-Blind, Randomized and Placebo-Controlled Clinical Trial, Complementary Therapies in Medicine (2018)
169. Trump Cannot Crush Iran's Scientists, Nature (2018)
170. A Randomized, Double-Blind Placebo-Controlled Trial on Effectiveness and Safety of Celecoxib Adjunctive Therapy in Adolescents With Acute Bipolar Mania, Journal of Child and Adolescent Psychopharmacology (2017)
171. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Alborz, Iran, Archives of Iranian Medicine (2017)
172. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Ardebil, Iran, Archives of Iranian Medicine (2017)
173. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Bushehr, Iran, Archives of Iranian Medicine (2017)
174. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Chaharmahal and Bakhtiari, Iran, Archives of Iranian Medicine (2017)
175. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of East Azarbaijan, Iran, Archives of Iranian Medicine (2017)
176. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Fars, Iran, Archives of Iranian Medicine (2017)
177. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Gilan, Iran, Archives of Iranian Medicine (2017)
178. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Golestan, Iran, Archives of Iranian Medicine (2017)
179. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Hamadan, Iran, Archives of Iranian Medicine (2017)
180. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Hormozgan, Iran, Archives of Iranian Medicine (2017)
181. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Isfahan, Iran, Archives of Iranian Medicine (2017)
182. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Isfahan, Iran, Archives of Iranian medicine (2017)
183. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Isfahan, Iran, Archives of Iranian Medicine (2017)
184. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Isfahan, Iran, Archives of Iranian medicine (2017)
185. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Kerman, Iran, Archives of Iranian Medicine (2017)
186. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Kohghilouyeh and Bouyerahmad, Iran, Archives of Iranian Medicine (2017)
187. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Lorestan, Iran, Archives of Iranian medicine (2017)
188. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Markazi, Iran, Archives of Iranian Medicine (2017)
189. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Mazandaran, Iran, Archives of Iranian Medicine (2017)
190. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of North Khorasan, Iran, Archives of Iranian Medicine (2017)
191. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Qazvin, Iran, Archives of Iranian Medicine (2017)
192. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Qazvin, Iran, Archives of Iranian medicine (2017)
193. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Qom, Iran, Archives of Iranian Medicine (2017)
194. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Razavi Khorasan, Iran, Archives of Iranian Medicine (2017)
195. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Sistan and Bluchestan, Iran, Archives of Iranian Medicine (2017)
196. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of South Khorasan, Iran, Archives of Iranian Medicine (2017)
197. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of Tehran, Iran, Archives of Iranian Medicine (2017)
198. A Survey on Mental Health Status of Adult Population Aged 15 and Above in the Province of West Azarbaijan, Iran, Archives of Iranian Medicine (2017)
199. Cilostazol Adjunctive Therapy in Treatment of Negative Symptoms in Chronic Schizophrenia: Randomized, Double-Blind, Placebo-Controlled Study, Human Psychopharmacology (2017)
200. Citicoline Combination Therapy for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial, Clinical Neuropharmacology (2017)
201. Comparison of Saffron and Fluvoxamine in the Treatment of Mild to Moderate Obsessive-Compulsive Disorder: A Double Blind, Randomized Clinical Trial, Iranian Journal of Psychiatry (2017)
202. Comparison of Saffron Versus Fluoxetine in Treatment of Mild to Moderate Postpartum Depression: A Double-Blind, Randomized Clinical Trial, Pharmacopsychiatry (2017)
203. Contribution of Health Researches in National Knowledge Production: A Scientometrics Study on 15-Year Research Products of Iran, International Journal of Preventive Medicine (2017)
204. Crocus Sativus L Versus Citalopram in the Treatment of Major Depressive Disorder With Anxious Distress: A Double-Blind, Controlled Clinical Trial, Pharmacopsychiatry (2017)
205. Development of Health Research Structures Over the Last 25 Years: Main Achievements and Challenges, Archives of Iranian Medicine (2017)
206. Diseases and Health Outcomes Registry Systems in I.R. Iran: Successful Initiative to Improve Public Health Programs, Quality of Care, and Biomedical Research, Archives of Iranian Medicine (2017)
207. Diseases and Health Outcomes Registry Systems in I.R. Iran: Successful Initiative to Improve Public Health Programs, Quality of Care, and Biomedical Research, Archives of Iranian medicine (2017)
208. Effect of Memantine Combination Therapy on Symptoms in Patients With Moderate-To-Severe Depressive Disorder: Randomized, Double-Blind, Placebo-Controlled Study, Journal of Clinical Pharmacy and Therapeutics (2017)
209. Efficacy and Safety of Celecoxib Monotherapy for Mild to Moderate Depression in Patients With Colorectal Cancer: A Randomized Double-Blind, Placebo Controlled Trial, Psychiatry Research (2017)
210. Female Infertility and Herbal Medicine, Journal of Medicinal Plants (2017)
211. Fluticasone Propionate in Clinically Suspected Asthma Patients With Negative Methacholine Challenge Test, Clinical Respiratory Journal (2017)
212. How to Assess Quality of Research in Iran, From Input to Impact? Introduction of Peer-Based Research Evaluation Model in Iran, Archives of Iranian Medicine (2017)
213. L-Carnosine As an Adjuvant to Fluvoxamine in Treatment of Obsessive Compulsive Disorder: A Randomized Double-Blind Study, Human Psychopharmacology (2017)
214. Medical Science and Research in Iran, Archives of Iranian Medicine (2017)
215. Melatonin for Reducing Weight Gain Following Administration of Atypical Antipsychotic Olanzapine for Adolescents With Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial, Journal of Child and Adolescent Psychopharmacology (2017)
216. Mental Health Survey of the Iranian Adult Population in 2015, Archives of Iranian Medicine (2017)
217. More Actions Needed to Reach a Consensus on Adjunctive Antidepressant Therapy for Negative Symptoms of Schizophrenia, Evidence-Based Mental Health (2017)
218. Pregnenolone As an Adjunct to Risperidone for Treatment of Women With Schizophrenia: A Randomized Double-Blind Placebo-Controlled Clinical Trial, Journal of Psychiatric Research (2017)
219. Research in Iran: Look on the Bright Side, Journal of Medicinal Plants (2017)
220. Research Ranking of Iranian Universities of Medical Sciences Based on International Indicators: An Experience From I.R. of Iran, Archives of Iranian Medicine (2017)
221. Role of Melatonin in Body Weight: A Systematic Review and Meta-Analysis, Current Pharmaceutical Design (2017)
222. Simvastatin Adjunct Therapy for Negative Symptoms of Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial, International Clinical Psychopharmacology (2017)
223. The Effect of Saffron (Crocus Sativus L.) Hydro-Alcoholic Extract on Liver and Renal Functions in Type 2 Diabetic Patients: A Double-Blinded Randomized and Placebo Control Trial, Journal of Nutrition and Intermediary Metabolism (2017)
224. The Effect of Saffron (Crocus Sativus L.) Hydro-Alcoholic Extract on Liver and Renal Functions in Type 2 Diabetic Patients: A Double-Blinded Randomized and Placebo Control Trial, Journal of Nutrition and Intermediary Metabolism (2017)
225. The Efficacy of Herbal Medicines for Treatment of Hot Flash: A Systematic Review, Journal of Medicinal Plants (2017)
226. The Reliability and Validity of the Persian Version of Three-Factor Eating Questionnaire-R18 (Tfeq-R18) in Overweight and Obese Females, Iranian Journal of Psychiatry (2017)
227. The Role of Medical Research Centers in Health Research System Promotion in I.R. of Iran: 2001–2014, Archives of Iranian Medicine (2017)
228. Tincture of Opium for Treating Opioid Dependence: A Systematic Review of Safety and Efficacy, Addiction (2017)
229. Trends of Mental Health Status in Iranian Population Aged 15 and Above Between 1999 and 2015, Archives of Iranian Medicine (2017)
230. Agomelatine As a Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Double-Blind, Randomized Clinical Trial, Journal of Child and Adolescent Psychopharmacology (2016)
231. Duloxetine Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia: Randomized Double-Blind Placebo-Controlled Study, Pharmacopsychiatry (2016)
232. Efficacy and Safety of Oral Ketamine Versus Diclofenac to Alleviate Mild to Moderate Depression in Chronic Pain Patients: A Double-Blind, Randomized, Controlled Trial, Journal of Affective Disorders (2016)
233. Evidence Based Medicine and Herbal Medicine, Journal of Medicinal Plants (2016)
234. Factors Associated With Anxiety in Premature Coronary Artery Disease Patients: Thc-Pac Study, Acta Medica Iranica (2016)
235. Factors Associated With Depressive Symptoms in Young Adults With Coronary Artery Disease: Tehran Heart Center's Premature Coronary Atherosclerosis Cohort (Thc-Pac) Study, Iranian Journal of Psychiatry (2016)
236. Health Research Governance: Introduction of a New Web-Based Research Evaluation Model in Iran: One-Decade Experience, Iranian Journal of Public Health (2016)
237. Herbal Medicine in the Treatment of Polycystic Ovary Syndrome, Journal of Medicinal Plants (2016)
238. Minocycline As Adjunctive Treatment to Risperidone in Children With Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial, Journal of Child and Adolescent Psychopharmacology (2016)
239. Minocycline Combination Therapy With Fluvoxamine in Moderate-To-Severe Obsessive–Compulsive Disorder: A Placebo-Controlled, Double-Blind, Randomized Trial, Psychiatry and Clinical Neurosciences (2016)
240. N-Acetylcysteine Augmentation Therapy for Moderate-To-Severe Obsessive-Compulsive Disorder: Randomized, Double-Blind, Placebo-Controlled Trial, Journal of Clinical Pharmacy and Therapeutics (2016)
241. Next Generation Sequencing: Implications in Personalized Medicine and Pharmacogenomics, Molecular BioSystems (2016)
242. Reliability and Validity of the Persian Version of Compulsive Eating Scale (Ces) in Overweight or Obese Women and Its Relationship With Some Body Composition and Dietary Intake Variables, Iranian Journal of Psychiatry (2016)
243. Riluzole Combination Therapy for Moderate-To-Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial, Journal of Psychiatric Research (2016)
244. Riluzole in Augmentation of Fluvoxamine for Moderate to Severe Obsessive–Compulsive Disorder: Randomized, Double-Blind, Placebo-Controlled Study, Psychiatry and Clinical Neurosciences (2016)
245. The Effects of Pioglitazone Adjuvant Therapy on Negative Symptoms of Patients With Chronic Schizophrenia: A Double-Blind and Placebo-Controlled Trial, Human Psychopharmacology (2016)
246. The Role of Lead Exposure on Attention-Deficit/Hyperactivity Disorder in Children: A Systematic Review, Iranian Journal of Psychiatry (2016)
247. The Role of Phthalate Esters in Autism Development: A Systematic Review, Environmental Research (2016)
248. The Trace of Evidence Based Medicine in Avicenna's Approaches, Journal of Medicinal Plants (2016)
249. Therapeutic Effects of Minocycline on Mild-To-Moderate Depression in Hiv Patients: A Double-Blind, Placebo-Controlled, Randomized Trial, International Clinical Psychopharmacology (2016)
250. A Pilot Double-Blind Placebo-Controlled Trial of Pioglitazone As Adjunctive Treatment to Risperidone: Effects on Aberrant Behavior in Children With Autism, Psychiatry Research (2015)
251. A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men With Chronic Schizophrenia, Acta Medica Iranica (2015)
252. Are Supplementation of Omega-3 and Ascorbic Acid Effective in Reducing Oxidative Stress and Depression Among Depressed Shift Workers?, International Journal for Vitamin and Nutrition Research (2015)
253. Celecoxib Adjunctive Therapy for Acute Bipolar Mania: A Randomized, Double-Blind, Placebo-Controlled Trial, Bipolar Disorders (2015)
254. Celecoxib As an Adjuvant to Fluvoxamine in Moderate to Severe Obsessive-Compulsive Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial, Pharmacopsychiatry (2015)
255. Celecoxib for the Treatment of Mild-To-Moderate Depression Due to Acute Brucellosis: A Double-Blind, Placebo-Controlled, Randomized Trial, Journal of Clinical Pharmacy and Therapeutics (2015)
256. Celecoxib Versus Diclofenac in Mild to Moderate Depression Management Among Breast Cancer Patients: A Double-Blind, Placebo-Controlled, Randomized Trial, Annals of Pharmacotherapy (2015)
257. Effect of Adjunctive Celecoxib on Bdnf in Manic Patients Undergoing Electroconvulsive Therapy: A Randomized Double Blind Controlled Trial, Pharmacopsychiatry (2015)
258. Establishment of the National Network of Who Collaborating Centres in Iran to Contribute to the National Public Health Needs, Archives of Iranian Medicine (2015)
259. Herbal Medicine for Women's Health, Journal of Medicinal Plants (2015)
260. Herbal Medicine in the Treatment of Primary Dysmenorrhea, Journal of Medicinal Plants (2015)
261. Lipoid Proteinosis: Phenotypic Heterogeneity in Iranian Families With C.507Delt Mutation in Ecm1, Experimental Dermatology (2015)
262. Memantine Versus Methylphenidate in Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Double-Blind, Randomized Clinical Trial, Iranian Journal of Psychiatry (2015)
263. N-Acetylcysteine As an Adjunctive Therapy to Risperidone for Treatment of Irritability in Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety, Clinical Neuropharmacology (2015)
264. Pioglitazone Adjunctive Therapy for Depressive Episode of Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial, Depression and Anxiety (2015)
265. Simvastatin As an Adjuvant Therapy to Fluoxetine in Patients With Moderate to Severe Major Depression: A Double-Blind Placebo-Controlled Trial, Journal of Psychopharmacology (2015)
266. Simvastatin Versus Atorvastatin for Improving Mild to Moderate Depression in Post-Coronary Artery Bypass Graft Patients: A Double-Blind, Placebo-Controlled, Randomized Trial, Journal of Affective Disorders (2015)
267. Sustained-Release Methylphenidate in Methamphetamine Dependence Treatment: A Double-Blind and Placebo-Controlled Trial, DARU# Journal of Pharmaceutical Sciences (2015)
268. Sustained-Release Methylphenidate in Methamphetamine Dependence Treatment: A Double-Blind and Placebo-Controlled Trial, DARU, Journal of Pharmaceutical Sciences (2015)
269. Total Antioxidant Capacity and Malondialdehyde in Depressive Rotational Shift Workers, Journal of Environmental and Public Health (2013)